This announcement details that the Shenzhen Stock Exchange has accepted the application from Tuoxin Pharmaceutical Group Co., Ltd. for issuing shares to specific objects in 2026. The application documents have been reviewed and deemed complete. The issuance is still subject to further review by the SZSE and approval from the China Securities Regulatory Commission.
Summary generated by AI · Always verify with source document
Stock Code: 301089
Stock Abbreviation: Tuoxin Pharmaceutical
Announcement No.: 2026-046
Tuoxin Pharmaceutical Group Co., Ltd.
Announcement on Shenzhen Stock Exchange's Acceptance of Application for Issuance of Shares to Specific Objects in 2026
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.